Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $5.5 million.

  • Mesa Laboratories' Shares Outstanding (Weighted Average) rose 1.71% to $5.5 million in Q3 2025 from the same period last year, while for Dec 2023 it was $5.4 million, marking a year-over-year increase of 1.03%. This contributed to the annual value of $5.4 million for FY2025, which is 0.73% up from last year.
  • Per Mesa Laboratories' latest filing, its Shares Outstanding (Weighted Average) stood at $5.5 million for Q3 2025, which was up 0.84% from $5.5 million recorded in Q2 2025.
  • Mesa Laboratories' 5-year Shares Outstanding (Weighted Average) high stood at $5.5 million for Q3 2025, and its period low was $5.1 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $5.4 million (2024), whereas its average is $5.4 million.
  • Data for Mesa Laboratories' Shares Outstanding (Weighted Average) shows a peak YoY increased of 17.42% (in 2021) over the last 5 years.
  • Mesa Laboratories' Shares Outstanding (Weighted Average) (Quarterly) stood at $5.2 million in 2021, then rose by 2.14% to $5.3 million in 2022, then rose by 1.03% to $5.4 million in 2023, then grew by 0.74% to $5.4 million in 2024, then grew by 1.71% to $5.5 million in 2025.
  • Its last three reported values are $5.5 million in Q3 2025, $5.5 million for Q2 2025, and $5.4 million during Q1 2025.